Doheny Asset Management CA Cuts Stake in Enovix Corporation $ENVX

Doheny Asset Management CA trimmed its position in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) by 48.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 107,044 shares of the company’s stock after selling 100,308 shares during the period. Doheny Asset Management CA’s holdings in Enovix were worth $782,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of ENVX. Vanguard Group Inc. boosted its holdings in shares of Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock valued at $129,831,000 after acquiring an additional 1,747,145 shares during the last quarter. Electron Capital Partners LLC boosted its holdings in shares of Enovix by 13.8% during the 3rd quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after acquiring an additional 972,103 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enovix by 6.1% during the 4th quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock valued at $32,268,000 after acquiring an additional 253,906 shares during the last quarter. CenterBook Partners LP boosted its holdings in shares of Enovix by 66.1% during the 4th quarter. CenterBook Partners LP now owns 1,757,382 shares of the company’s stock valued at $12,846,000 after acquiring an additional 699,519 shares during the last quarter. Finally, Granahan Investment Management LLC boosted its holdings in shares of Enovix by 17.5% during the 3rd quarter. Granahan Investment Management LLC now owns 1,749,649 shares of the company’s stock valued at $17,444,000 after acquiring an additional 260,085 shares during the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.

Get Enovix alerts:

Enovix Stock Performance

ENVX opened at $7.28 on Monday. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. The company has a market cap of $1.59 billion, a price-to-earnings ratio of -8.77 and a beta of 2.27. The company’s 50 day moving average is $6.50 and its 200 day moving average is $6.78. Enovix Corporation has a 12-month low of $4.61 and a 12-month high of $16.49.

Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The firm’s revenue was up 49.1% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts predict that Enovix Corporation will post -0.79 EPS for the current year.

Analysts Set New Price Targets

ENVX has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a report on Friday, April 10th. Canaccord Genuity Group dropped their price target on shares of Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Bank of America initiated coverage on shares of Enovix in a report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price target on the stock. TD Cowen reaffirmed a “buy” rating on shares of Enovix in a report on Thursday, May 14th. Finally, Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. Seven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $12.64.

Check Out Our Latest Report on ENVX

About Enovix

(Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Recommended Stories

• Five stocks we like better than Enovix
• These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
• 3 Stocks Under $20 to Buy Before a Broader Market Rally
• Petco Faces Tough Competition, But Momentum Is Building
• The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.